In Europe, human infections with "Candidatus Neoehrlichia mikurensis" have mainly been restricted to immunocompromised patients. We report here the first cases of asymptomatic "Ca. Neoehrlichia mikurensis" infection in immunocompetent humans (5/316 [1.6%] were infected). Due to the potential threats of infections with "Ca. Neoehrlichia mikurensis" in healthy persons to the safety of the blood supply, further study of this phenomenon is required.
struction method and the Hasegawa-Kishino-Yano parameter algorithm as a distance method. For comparison, the sequences of "Ca. Neoehrlichia mikurensis" obtained from GenBank (www .ncbi.nlm.nih.gov) were included in the sequence alignment.
Among the 316 studied foresters, 5 cases (1.6%) of asymptomatic infection with "Ca. Neoehrlichia mikurensis" were diagnosed. The positive blood samples were collected in early July 2012 from 4 men and one woman working in the Czerwony Dwór, Gołdap (Warmiń sko-Mazurskie), and Suwałki (Podlaskie) regions. Infection with this bacterium was also diagnosed from the sample taken in early November 2012 from one of the same men from Czerwony Dwór. No "Ca. Neoehrlichia mikurensis" morulae were observed on the Giemsa-stained blood smears. The nucleotide sequences of all of the amplified 16S rRNA gene fragments (430 bp; nucleotide positions 5=-3= of amplified fragment, 133 to 563; number corresponds to the nucleotide positions relative to the sequence of the 16S rRNA gene [1,426 bp] of "Ca. Neoehrlichia mikurensis" [GenBank accession no. EU810404]) were identical to those of the "Ca. Neoehrlichia mikurensis" isolates obtained from infected humans in Switzerland (GQ501090), Germany (EU810404), and China (JQ359045), as well as from I. ricinus collected in Slovakia (JN378917) and Germany (EU810405), I. persulcatus collected in Russia (FJ966362), and Apodemus spp. collected in Japan (AB196305). Since the 16S rRNA gene is too highly conserved for an analysis of genetic heterogeneity, partial groESL operon fragments (920 bp; nucleotide positions 5=-3= of amplified fragment, 248 to 1168; number corresponds to the nucleotide positions relative to the sequence of the groESL [1,233 bp] of "Ca. Neoehrlichia mikurensis" [EU810406]) amplified from all positive samples were also sequenced. The nucleotide sequences of all 5 isolates were identical and showed 100% identity to the groESL sequences of the "Ca. Neoehrlichia mikurensis" isolates obtained from I. ricinus ticks, rodents, a dog, and a human from Europe ( Fig. 1) . The DNA sequences amplified from our human "Ca. Neoehrlichia mikurensis" isolates were also identical to those obtained from ticks and bank voles collected in Warmiń sko-Mazurskie province in our previous studies (5) . However, the phylogenetic tree of the partial groESL operon sequences showed that two European "Ca. Neoehrlichia mikurensis" isolates from a bank vole and a human (Switzerland) differed by 3 and 13 nucleotides, respectively. Phylogenetic analysis revealed that differences in the groESL sequence were sufficient to differentiate the European and Chinese variants of the species "Ca. Neoehrlichia mikurensis" (Fig. 1) . Similar molecular analyses for Babesia, Anaplasma, Ehrlichia, Rickettsia (5), and Borrelia (7) species did not demonstrate any active coinfection in our 5 "Ca. Neoehrlichia mikurensis"-positive foresters.
Prior to this study, 8 cases of human infection with "Ca. Neoehrlichia mikurensis" had been described in Europe (2), and 7 more were recently reported in China (14) . Little is known about the distribution, risk areas, and zoonotic reservoir of this bacterium, and its pathogenic mechanisms remain largely uncharacterized. Like all members of the family Anaplasmataceae,"Ca. Neoehrlichia mikurensis" is an obligate intracellular pathogen that resides within the cytoplasm of endothelial cells (1) . The symptoms produced by infections with this pathogen in immunocompromised patients may be severe and can include aneurysm, thromboembolic complications, subcutaneous hemorrhages, and erythematous rashes (10) (11) (12) (13) . Until now, asymptomatic infection in immunocompetent people had not been reported, although most Ehrlichia infections are known to be either asymptomatic or mild self-limiting diseases (16) . The present study describes five new asymptomatic human cases of "Ca. Neoehrlichia mikurensis" infection in healthy foresters working in the northeastern part of Poland, where I. ricinus ticks are endemic, and all of the infected individuals recalled a recent tick bite. Human infections caused by this bacterium have been recognized as an emerging problem in the last decade, and this is most likely due to ecological changes and the resulting expansion of Ixodidae tick populations. Due to the potentially serious nature of disease caused by "Ca. Neoehrlichia mikurensis" in immunocompromised individuals, further study of this bacterium, its tick vectors, and reservoir hosts is urgently required, as is the establishment of a European ecoepidemiological monitoring program for this infection. It should also be emphasized that the identification of new blood-borne infectious agents, especially in immunocompetent humans, demands further research in order to determine the potential threat they may pose to the blood supply (17) . Eight transfusion-transmitted cases of Anaplasma phagocytophilum infection (18) and a single case of ehrlichiosis acquired from a transfusion of blood products have been documented in the literature to date (19) . However, A. phagocytophilum and Ehrlichia spp. remain viable under refrigeration conditions at 4°C for up to 18 days, enabling the potential transmission of infection by blood transfusion (20) . Thus, the increasing spread of vectors and reservoirs make the new and wellknown tick-borne pathogens important to monitor and a future target for possible donation screening or inactivation by pathogen reduction technologies.
Nucleotide sequence accession numbers. The new 16S rRNA gene and groESL operon sequences from CNM present in the blood samples of healthy humans in Poland have been deposited in GenBank under accession no. KJ123754 and KJ561571.
